Drug intelligence / Profile preview

Suting Soup

Development stage: Preclinical
Lead developer: Nestlé
Administration: Oral

Overview

Suting Soup is a Traditional Chinese Medicine (TCM) formulation that was investigated as an intervention for childhood bronchial asthma in a clinical trial. The study, conducted by Children's Hospital, Zhejiang University School of Medicine and funded by the Provincial Science and Technology Department, aimed to evaluate its efficacy in a Chinese and Western medicine treatment approach.

Targets

IL-6 (Interleukin 6)MMP9 (Matrix metalloproteinase-9)IL-4 (Interleukin 4)CCL2 (C-C motif chemokine 2)TGFB1 (Transforming growth factor Beta-1 proprotein)

Beyond the preview

Go deeper on Suting Soup.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suting Soup.

Explore the full profile